4880.T
Price:
$435
Market Cap:
$8.62B
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2019-10-29
Stock Exchange
JPX
Ticker
4880.T
According to CellSource Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.23B. This represents a change of -66.29% compared to the average of 12.54B of the last 4 quarters.
The mean historical Enterprise Value of CellSource Co., Ltd. over the last ten years is 41.55B. The current 4.23B Enterprise Value has changed 917.62% with respect to the historical average. Over the past ten years (40 quarters), 4880.T's Enterprise Value was at its highest in in the October 2021 quarter at 117.85B. The Enterprise Value was at its lowest in in the July 2019 quarter at -217434000.00.
Average
41.55B
Median
24.12B
Minimum
9.86B
Maximum
118.35B
Discovering the peaks and valleys of CellSource Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 245.29%
Maximum Annual Enterprise Value = 118.35B
Minimum Annual Increase = -63.26%
Minimum Annual Enterprise Value = 9.86B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 19.26B | -33.55% |
| 2023 | 28.99B | -63.26% |
| 2022 | 78.90B | -33.34% |
| 2021 | 118.35B | 139.65% |
| 2020 | 49.39B | 245.29% |
| 2019 | 14.30B | 45.12% |
| 2018 | 9.86B | -26.17% |
The current Enterprise Value of CellSource Co., Ltd. (4880.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
42.38B
5-year avg
58.98B
10-year avg
41.55B
CellSource Co., Ltd.’s Enterprise Value is less than Stella Pharma Corporation (6.09B), less than MEDINET Co., Ltd. (5.39B), greater than MediciNova, Inc. (41.81M), less than Chiome Bioscience Inc. (6.56B), less than NANO MRNA Co.,Ltd. (9.37B), less than StemCell Institute Inc. (5.36B), less than GENOVA, Inc. (5.12B), less than Kohjin Bio Co., Ltd. (7.08B), greater than Linical Co., Ltd. (3.39B), less than Kidswell Bio Corporation (9.07B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 6.09B | $8.20B | |
| 5.39B | $7.94B | |
| 41.81M | $11.67B | |
| 6.56B | $7.48B | |
| 9.37B | $10.33B | |
| 5.36B | $7.95B | |
| 5.12B | $9.69B | |
| 7.08B | $7.72B | |
| 3.39B | $6.69B | |
| 9.07B | $10.36B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CellSource Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CellSource Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CellSource Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for CellSource Co., Ltd. (4880.T)?
What is the 3-year average Enterprise Value for CellSource Co., Ltd. (4880.T)?
What is the 5-year average Enterprise Value for CellSource Co., Ltd. (4880.T)?
How does the current Enterprise Value for CellSource Co., Ltd. (4880.T) compare to its historical average?